Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Impax Laboratories Enters Into Development Agreement with Perrigo
Yahoo
Thursday, August 5, 2010 - 11:19am
tags:
Impax, drug development, Perrigo Company
Botox to Breast Implants: What's Next for Allergan?
CNBC
Thursday, August 5, 2010 - 9:39am
tags:
Botox, Allergan
No Nail Yet, but Vertex Creeps Up to Merck's Coffin
Motley Fool
Thursday, August 5, 2010 - 9:27am
tags:
Merck, Vertex Pharmaceuticals, Telaprevir, Boceprevir, hepatitis C
[video] What's Genzyme Worth to Sanofi?
TheStreet.com
Thursday, August 5, 2010 - 9:24am
tags:
M&A, Sanofi, Genzyme
3 Big Bets on Health Care
Yahoo/Motley Fool
Thursday, August 5, 2010 - 9:23am
tags:
Abbott Laboratories, Immunogen, Amgen
Merck's Hepatitis C Treatment Suppresses Virus In Two Large-Scale Studies
Bloomberg
Thursday, August 5, 2010 - 8:10am
tags:
Merck, hepatitis C, clinical trials, Boceprevir
How Much Is Abbott Labs Worth?
Motley Fool
Thursday, August 5, 2010 - 8:09am
tags:
Abbott Laboratories
One Biotech Stock Ready to Rebound?
Motley Fool
Thursday, August 5, 2010 - 8:09am
tags:
Elan
Ariad posts 2Q profit on cancer drug payments
Yahoo/AP
Thursday, August 5, 2010 - 8:08am
tags:
Ariad Pharmaceuticals, earnings
Santarus Beats on Higher Revs
Yahoo/Zacks.com
Wednesday, August 4, 2010 - 1:48pm
tags:
earnings, Santarus
Sanofi Investors Oppose Big Hike in Genzyme Bid
NY Times, NY
Wednesday, August 4, 2010 - 1:37pm
tags:
Sanofi, Genzyme, M&A
Big Pharma Won't Wait in Rush for Biotech's Drugs
WSJ Online
Wednesday, August 4, 2010 - 11:30am
tags:
Bristol-Myers Squibb, ZymoGenetics, Amgen, Big Pharma, Abbott Laboratories, Array Biopharma
Pharma Job Cuts Are On The Rise Again
Pharmalot
Wednesday, August 4, 2010 - 11:11am
tags:
layoffs
ZymoGenetics 2Q loss narrows on sales, revenue
Yahoo/AP
Wednesday, August 4, 2010 - 11:09am
tags:
ZymoGenetics, earnings
Up in Smoke: Pfizer Spent $6 Billion Restructuring Since Wyeth Merger
BNET Pharma
Wednesday, August 4, 2010 - 8:01am
tags:
Pfizer, Wyeth, restructuring, M&A
Shire quarterly profit more than triples
Marketwatch
Wednesday, August 4, 2010 - 7:59am
tags:
Shire, earnings
Genzyme and Isis Report Results of Two Phase 3 Trials of Mipomersen
Yahoo
Wednesday, August 4, 2010 - 7:57am
tags:
Genzyme, Isis Pharmaceuticals, mipomersen, cholesterol, clinical trials
For Dendreon, It’s 500 Prescriptions for Provenge and Counting
WSJ Online
Wednesday, August 4, 2010 - 7:56am
tags:
Dendreon, Provenge, vaccines, prostate cancer
Most Americans Say Drug Safety Is Lacking
Pharmalot
Wednesday, August 4, 2010 - 7:55am
tags:
drug safety
How Eli Lilly Let a Billion-Dollar Molecule Slip Away, and Make a Fortune for Vertex
Xconomy
Wednesday, August 4, 2010 - 7:52am
tags:
Vertex Pharmaceuticals, Eli Lilly, Telaprevir, hepatitis C

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.